PPP 196 - Long-acting injectable buprenorphine (LAIB) with Conjoint Professor Nicholas Lintzeris
Purple Pen PodcastShow Notes
In this episode, Professor Nicholas Lintzeris joins us to discuss where LAIB fits in contemporary opioid dependence treatment, how it compares with methadone and sublingual buprenorphine, and which patients are most likely to benefit. We also explore practical aspects of initiation, dosing, administration, management of adverse effects, and common misconceptions surrounding depot buprenorphine therapy. Sublocade, will be removed from Australian markets at the end of 2026 . Made by US-based pharmaceutical company Indivior, the medication is one of two long-acting, slow-release buprenorphine injections on the Pharmaceutical Benefits Scheme (PBS) for opioid dependence treatment. Buvidal, remains available on the PBS. Further reading and resources https://theconversation.com/buvidal-is-it-really-a-game-changer-in-the-treatment-of-problematic-opioid-use-214895
NSW Guideline - https://www.health.nsw.gov.au/aod/resources/Pages/laib.aspx
More from Purple Pen Podcast
In this episode we celebrate our ten‑year podcast anniversary with guest Angus Thompson, a consulting clinical pharmacist and clinical editor who works across Southern Tasmania. We open with a quick roll call of the B‑group vitamins to set the scene before shifting into the main focus of the conversation: how Vitamin B6 became a ubiquitous ingredient in sleep products, menopause supplements, energy blends, magnesium powders and everyday multivitamins. Angus explains why B6 deficiency is relatively uncommon, why it still appears in so many products, and how recommended daily intakes are exceeded in many supplements. We discuss what B6 is actually indicated for, the most common forms found in supplements, and why assumptions about "water‑soluble vitamins being harmless" have not held up in practice. The heart of the episode looks at B6 toxicity and its link to peripheral neuropathy, what symptoms clinicians should look for, how it's diagnosed, potential for long term harm, and why many patients don't realise their supplements could be contributing. We also talk through the TGA's strengthened safety controls announced in November 2025 and whether recent media coverage has helped or confused the public conversation. Further information can be found here: Stronger safety controls to be introduced for products containing vitamin B6: https://www.tga.gov.au/news/media-releases/stronger-safety-controls-be-introduced-products-containing-vitamin-b6 Scientific opinion on the tolerable upper intake level for vitamin B6: https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2023.8006
In this episode, Kristin sits down with Melbourne-based community pharmacist Anna Theophilos, the Pharmaceutical Society of Australia's inaugural Vaccination Ambassador, for a deep dive into the world of pharmacist-led injectable medicines administration. Anna brings her expertise on everything from injection technique to patient hesitancy, offering practical insight for pharmacists looking to build confidence and consistency in this growing area of practice. In this episode, Kristin and Anna discuss: The role of pharmacists and the pharmacy workforce in facilitating injectable medicines administration — whether that's giving injections directly or supporting patients to safely self-administer
In this episode, Dr Evan Tseros, Otolaryngologist, Head & Neck Surgeon, joins us to discuss the different types of otitis media, how to distinguish it from conditions such as otitis externa and eustachian tube dysfunction, and the assessment of otalgia, including important causes of referred ear pain. We also explore current management recommendations, the role of antibiotics, key red flags, and practical safety-netting advice for pharmacists.
PPP 194 – Sport and Exercise Pharmacy with Alison Hooper In this episode, pharmacist and former physiotherapist Alison Hooper joins us to discuss the expanding role of pharmacists in sport, exercise, and active living We cover: How pharmacists can support movement, exercise, and sport Injury management and common sports-related conditions Managing chronic conditions in active people Exercise-induced asthma Therapeutic Use Exemptions (TUEs) WADA and anti-doping regulations Accidental doping risks from supplements RICER vs PEACE & LOVE for injury management The latest evidence on NSAIDs in sport Whether you're working with elite athletes or helping patients stay active, this episode highlights the important role pharmacists play in supporting safe participation in sport and exercise.
To align with NAIDOC week this year we have a special bonus episode. In this episode, we speak with Dr Jessica Buck about childhood cancer in First Nations people, genomics, and the importance of cultural safety in healthcare and research. A proud Kamilaroi woman, she is the Team Leader of the First Nations Childhood Cancer Program at The Kids Research Institute Australia — a first-of-its-kind initiative dedicated to developing culturally safe, community-led research strategies to improve outcomes for First Nations children with cancer. Together, we explore how a First Nations perspective can strengthen biomedical science and improve care for Aboriginal and Torres Strait Islander children and families affected by cancer. We cover: What culturally safe healthcare and research look like in practice